AC
FCSC

Armistice Capital’s Fibrocell Science Inc. FCSC Stock Holding History

Armistice Capital’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-122,779
Closed -$393K – 84
2017
Q4 		$393K Buy
+122,779
New +$1.07M 0.04% 66

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Armistice Capital's FCSC Position: Q1 2018 in Review

Armistice Capital sold out of Fibrocell Science Inc. (FCSC) in Q1 2018, closing a stake of 122,779 shares — an estimated $393K sold.

Armistice Capital first reported a position in FCSC in Q4 2017 and held it in 1 quarter. The position peaked at $393K in Q4 2017. 30 funds tracked by Wall St. Rank hold FCSC as of Q1 2018.

  • Armistice Capital reported no remaining Fibrocell Science Inc. position as of Q1 2018 after selling out during the quarter.
  • Armistice Capital sold 122,779 Fibrocell Science Inc. shares in Q1 2018, an estimated $393K.
  • Armistice Capital first reported a position in Fibrocell Science Inc. in Q4 2017 and held it in 1 quarter.
  • Armistice Capital's Fibrocell Science Inc. position peaked at $393K in Q4 2017.
  • 30 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q1 2018.

Based on Armistice Capital's 13F filing for Q1 2018, filed 15 May 2018.